by FBorchert | May 26, 2023 | News
Once again we will be attending the premier event for education, science, research and networking in nuclear medicine and molecular imaging – SNMMI 2023 – you will find us in Chicago, Illinois, June 24-27, Booth #3082. We have been an almost annual...
by FBorchert | May 8, 2023 | News
Our General Manager Andreas Fintelmann is heading to Honolulu in May to attend the 25th iSRS conference. From 22-25.5. there will be an outstanding collection of plenaries and workshops. A great opportunity to reactivate old connections and make new ones while in the...
by FBorchert | Nov 14, 2022 | News
Meet ABX-CRO executives at the TRP 2022 Annual Meeting December 6-8 | Amsterdam. Join us for our presentation about taking Radipharmaceuticals to their next evulitionary...
by FBorchert | Jun 1, 2022 | News
ABX-CRO at SNMMI 2022 Meet ABX-CRO executives at the SNMMI 2022 Annual Meeting June 11-14 | Vancouver, BC, at booth no. # 649. Celebrate with us our inauguration of our Boston-based US branch ABX-CRO Inc., further strengthening our global operations, and see the...
by FBorchert | May 24, 2022 | News
Andreas Fintelmann, leading radiopharmaceutical and precursor industry expert and executive joins ABX-CRO as managing director to support the further global expansion and growth of ABX-CRO. Andreas Fintelmann states “I am delighted to join ABX-CRO and reunite with...
by FBorchert | Oct 28, 2021 | News
Preclinical and clinical evaluation of radiopharmaceuticals can be sometimes seen as straightforward compared to non-radioactive molecules as the injected doses are often below toxic doses. However, the development of theranostics requires highly specific expertise...
